Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (DEFICIT)

v3.22.2.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020 $ 3 $ 48,670 $ (2,860) $ (36,962) $ 8,851
Balance at the beginning (in shares) at Dec. 31, 2020 27,483,350        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       6,864 6,864
Foreign currency translation adjustments     284   284
Balance at the end at Mar. 31, 2021 $ 3 48,670 (2,576) (30,098) 15,999
Balance at the end (in shares) at Mar. 31, 2021 27,483,350        
Balance at the beginning at Dec. 31, 2020 $ 3 48,670 (2,860) (36,962) 8,851
Balance at the beginning (in shares) at Dec. 31, 2020 27,483,350        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)         8,373
Foreign currency translation adjustments         23
Balance at the end at Sep. 30, 2021 $ 3 48,670 (2,747) (38,589) 7,337
Balance at the end (in shares) at Sep. 30, 2021 27,483,350        
Balance at the beginning at Mar. 31, 2021 $ 3 48,670 (2,576) (30,098) 15,999
Balance at the beginning (in shares) at Mar. 31, 2021 27,483,350        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       6,815 6,815
Foreign currency translation adjustments     254   254
Balance at the end at Jun. 30, 2021 $ 3 48,670 (2,322) (23,283) 23,068
Balance at the end (in shares) at Jun. 30, 2021 27,483,350        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       (5,306) (5,306)
Dividends declared       (10,000) (10,000)
Foreign currency translation adjustments     (515)   (515)
Change in fair value of derivative instruments     90   90
Balance at the end at Sep. 30, 2021 $ 3 48,670 (2,747) (38,589) 7,337
Balance at the end (in shares) at Sep. 30, 2021 27,483,350        
Balance at the beginning at Dec. 31, 2021 $ 3 127,606 (1,917) (37,052) $ 88,640
Balance at the beginning (in shares) at Dec. 31, 2021 34,383,350       34,383,350
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       (10,165) $ (10,165)
Dividends declared       (2,750) (2,750)
Stock-based compensation   22,436     22,436
Common stock issued under employee compensation plans   1,152     1,152
Common stock issued under employee compensation plans (in shares) 580,990        
Common stock withheld related to net share settlement of stock-based compensation   (6,216)     (6,216)
Common stock withheld related to net share settlement of stock-based compensation (in shares) (182,069)        
Foreign currency translation adjustments     (360)   (360)
Change in fair value of derivative instruments     3,208   3,208
Balance at the end at Mar. 31, 2022 $ 3 144,978 931 (49,967) 95,945
Balance at the end (in shares) at Mar. 31, 2022 34,782,271        
Balance at the beginning at Dec. 31, 2021 $ 3 127,606 (1,917) (37,052) $ 88,640
Balance at the beginning (in shares) at Dec. 31, 2021 34,383,350       34,383,350
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)         $ (779)
Foreign currency translation adjustments         (5,237)
Balance at the end at Sep. 30, 2022 $ 4 203,754 (846) (46,352) $ 156,560
Balance at the end (in shares) at Sep. 30, 2022 37,332,271       37,332,271
Balance at the beginning at Mar. 31, 2022 $ 3 144,978 931 (49,967) $ 95,945
Balance at the beginning (in shares) at Mar. 31, 2022 34,782,271        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       4,445 4,445
Issuance of common share in secondary offering, net of underwriter discounts and issuance costs $ 1 46,987     46,988
Issuance of common share in secondary offering, net of underwriter discounts and issuance costs (in shares) 2,250,000        
Dividends declared       (2,783) (2,783)
Stock-based compensation   2,739     2,739
Foreign currency translation adjustments     (2,038)   (2,038)
Change in fair value of derivative instruments     1,002   1,002
Balance at the end at Jun. 30, 2022 $ 4 194,704 (105) (48,305) 146,298
Balance at the end (in shares) at Jun. 30, 2022 37,032,271        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       4,941 4,941
Issuance of common share in secondary offering, net of underwriter discounts and issuance costs   6,389     6,389
Issuance of common share in secondary offering, net of underwriter discounts and issuance costs (in shares) 300,000        
Dividends declared       (2,988) (2,988)
Stock-based compensation   2,661     2,661
Foreign currency translation adjustments     (2,839)   (2,839)
Change in fair value of derivative instruments     2,098   2,098
Balance at the end at Sep. 30, 2022 $ 4 $ 203,754 $ (846) $ (46,352) $ 156,560
Balance at the end (in shares) at Sep. 30, 2022 37,332,271       37,332,271